Two novel mutations in the EIF2AK3 gene in children with Wolcott-Rallison syndrome
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | REIS, Andre F. | |
dc.contributor.author | KANNENGIESSER, Caroline | |
dc.contributor.author | JENNANE, Farida | |
dc.contributor.author | MANNA, Thais Della | |
dc.contributor.author | CHEURFA, Nadir | |
dc.contributor.author | OUDIN, Claire | |
dc.contributor.author | SAVOLDELLI, Roberta Diaz | |
dc.contributor.author | OLIVEIRA, Carolina | |
dc.contributor.author | GRANDCHAMP, Bernard | |
dc.contributor.author | KOK, Fernando | |
dc.contributor.author | VELHO, Gilberto | |
dc.date.accessioned | 2017-11-27T16:39:40Z | |
dc.date.available | 2017-11-27T16:39:40Z | |
dc.date.issued | 2011 | |
dc.description.abstract | Wolcott-Rallison syndrome (WRS, OMIM 226980) is a rare autosomal recessive disorder characterized by permanent neonatal diabetes mellitus, epiphyseal dysplasia, and other multisystemic clinical manifestations. We described two novel mutations in the EIF2AK3 gene in two consanguineous families with WRS from Brazil and Morocco. We have observed in case 1 a homozygous C > T replacement at base pair c.1192 at exon 7, generating a stop codon at position 398 (Gln398Stop). Both of his parents were found to be heterozygous for the mutation. We detected in both parents of case 2, a deceased Moroccan girl, a duplication of base pair c.851A at exon 5 (c.851dupA) leading to a frameshift and a stop codon at position 285 (p.Pro285AlafsX3). Both cases 1 and 2 had neonatal diabetes mellitus, multiple epiphyseal dysplasia, and growth delay, and presented episodes of acute hepatic dysfunction. Case 1 presented central hypothyroidism, developmental delay, and mild mental retardation. Case 2 presented a fatal episode of acute renal failure. The clinical phenotype associated with the syndrome can be variable, but a combination of infancy-onset diabetes mellitus, multiple epiphyseal dysplasia, and hepatic and/or renal dysfunction is the mainstay of diagnosis. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | CAPES, Brazil [1798-09-0] | |
dc.description.sponsorship | Societe Francophone du Diabete (SFD - Alfediam) | |
dc.identifier.citation | PEDIATRIC DIABETES, v.12, n.3, p.187-191, 2011 | |
dc.identifier.doi | 10.1111/j.1399-5448.2010.00679.x | |
dc.identifier.issn | 1399-543X | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/23807 | |
dc.language.iso | eng | |
dc.publisher | WILEY-BLACKWELL | |
dc.relation.ispartof | Pediatric Diabetes | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright WILEY-BLACKWELL | |
dc.subject | bone dysplasia | |
dc.subject | diabetes mellitus | |
dc.subject | EIF2AK3 | |
dc.subject | WRS | |
dc.subject.other | unfolded protein response | |
dc.subject.other | cell-survival | |
dc.subject.other | kinase | |
dc.subject.other | perk | |
dc.subject.other | translation | |
dc.subject.other | stress | |
dc.subject.wos | Endocrinology & Metabolism | |
dc.subject.wos | Pediatrics | |
dc.title | Two novel mutations in the EIF2AK3 gene in children with Wolcott-Rallison syndrome | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Marrocos | |
hcfmusp.affiliation.country | França | |
hcfmusp.affiliation.countryiso | fr | |
hcfmusp.affiliation.countryiso | ma | |
hcfmusp.author.external | REIS, Andre F.:Univ Fed Sao Paulo, Endocrinol Unit, Sao Paulo, Brazil | |
hcfmusp.author.external | KANNENGIESSER, Caroline:Hop Bichat Claude Bernard, AP HP, Lab Biochim Hormonale & Genet, F-75877 Paris 18, France; Univ Paris 07, UFR Med Site, F-75018 Paris, France | |
hcfmusp.author.external | JENNANE, Farida:Hop Enfants, CHU Ibn Rochd, Serv Pediat 2, Casablanca, Morocco | |
hcfmusp.author.external | CHEURFA, Nadir:INSERM, Res Unit 695, Paris, France | |
hcfmusp.author.external | SAVOLDELLI, Roberta Diaz:Univ Sao Paulo, Hosp Clin, Inst Crianca, Endocrine Pediat Unit, Sao Paulo, Brazil | |
hcfmusp.author.external | OLIVEIRA, Carolina:Univ Fed Sao Paulo, Endocrinol Unit, Sao Paulo, Brazil; Hop Bichat Claude Bernard, AP HP, Lab Biochim Hormonale & Genet, F-75877 Paris 18, France | |
hcfmusp.author.external | GRANDCHAMP, Bernard:Hop Bichat Claude Bernard, AP HP, Lab Biochim Hormonale & Genet, F-75877 Paris 18, France; Univ Paris 07, UFR Med Site, F-75018 Paris, France | |
hcfmusp.author.external | VELHO, Gilberto:INSERM, Res Unit 695, Paris, France | |
hcfmusp.contributor.author-fmusphc | THAIS DELLA MANNA | |
hcfmusp.contributor.author-fmusphc | FERNANDO KOK | |
hcfmusp.description.beginpage | 187 | |
hcfmusp.description.endpage | 191 | |
hcfmusp.description.issue | 3 | |
hcfmusp.description.volume | 12 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 21518408 | |
hcfmusp.origem.wos | WOS:000289892200009 | |
hcfmusp.publisher.city | MALDEN | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Brickwood S, 2003, J MED GENET, V40, P685, DOI 10.1136/jmg.40.9.685 | |
hcfmusp.relation.reference | Engelmann G, 2008, J INHERIT METAB DIS, V31, P540, DOI 10.1007/s10545-008-0867-0 | |
hcfmusp.relation.reference | Stiehm ER, 2008, J IMMUNOTOXICOL, V5, P227, DOI 10.1080/15476910802129646 | |
hcfmusp.relation.reference | Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5 | |
hcfmusp.relation.reference | Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002 | |
hcfmusp.relation.reference | Ozbek MN, 2010, PEDIATR DIABETES, V11, P279, DOI 10.1111/j.1399-5448.2009.00591.x | |
hcfmusp.relation.reference | Thornton CM, 1997, PEDIATR PATHOL LAB M, V17, P487, DOI 10.1080/107710497174778 | |
hcfmusp.relation.reference | Castelnau P, 2000, EUR J PEDIATR, V159, P631, DOI 10.1007/PL00008394 | |
hcfmusp.relation.reference | Iyer S, 2004, ACTA PAEDIATR, V93, P1195, DOI 10.1080/08035250410029362 | |
hcfmusp.relation.reference | Bin-Abbas B, 2002, AM J MED GENET, V111, P187, DOI 10.1002/ajmg.10495 | |
hcfmusp.relation.reference | Rubio-Cabezas O, 2009, J CLIN ENDOCR METAB, V94, P4162, DOI 10.1210/jc.2009-1137 | |
hcfmusp.relation.reference | Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JC126373 | |
hcfmusp.relation.reference | Adler SM, 2007, ENDOCRIN METAB CLIN, V36, P657, DOI 10.1016/j.ecl.2007.04.007 | |
hcfmusp.relation.reference | Senee V, 2004, DIABETES, V53, P1876, DOI 10.2337/diabetes.53.7.1876 | |
hcfmusp.relation.reference | Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7 | |
hcfmusp.relation.reference | Biason-Lauber A, 2002, DIABETES, V51, P2301, DOI 10.2337/diabetes.51.7.2301 | |
hcfmusp.relation.reference | Delepine M, 2000, NAT GENET, V25, P406 | |
hcfmusp.relation.reference | Bin-Abbas B, 2001, ANN SAUDI MED, V21, P73 | |
hcfmusp.relation.reference | Durocher F, 2006, CLIN GENET, V70, P34, DOI 10.1111/j.1399-0004.2006.00632.x | |
hcfmusp.relation.reference | Harding HP, 1999, NATURE, V397, P271 | |
hcfmusp.relation.reference | JENNANE F, 2005, REV MAR MAL ENF, V5, P41 | |
hcfmusp.relation.reference | Marafie MJ, 2004, ANN SAUDI MED, V24, P476 | |
hcfmusp.relation.reference | Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056 | |
hcfmusp.relation.reference | SOVIK O, 2008, J INHERIT METAB DIS, DOI 10.1007/S10545-10008-10866-10541 | |
hcfmusp.relation.reference | Wolcott C D, 1972, J Pediatr, V80, P292, DOI 10.1016/S0022-3476(72)80596-1 | |
relation.isAuthorOfPublication | 0fe90d92-c320-4300-be53-bd33ceab0de4 | |
relation.isAuthorOfPublication | ce9d8f9a-caa7-4fdb-bcff-9b2a926cd997 | |
relation.isAuthorOfPublication.latestForDiscovery | 0fe90d92-c320-4300-be53-bd33ceab0de4 |